- Home
- Applications
- USA
- gastrointestinal
Show results for
Refine by
Gastrointestinal Product Applications In Usa
9 applications found
Acute gastroenteritis and gastritis are characterized by inflammation of the mucus membranes of the gastrointestinal tract, most commonly caused by viral infection, with symptoms including nausea, vomiting, diarrhea and abdominal ...
ByRedHill Biopharma Ltd. based in Tel-Aviv, ISRAEL
We have designed a range of breath monitors that are non invasive and low cost to aid in the detection of gastrointestinal disorders such as SIBO. lactose intolerance, fructose intolerance, glucose intolerance and many others. The breath tests are easy to perform and multiple patients can be tested for gastrointestinal disorders in one session with our breath ...
ByBedfont Scientific Limited based in Kent, UNITED KINGDOM
A defective gastrointestinal (GI) barrier is associated with multiple conditions of high unmet need, including inflammatory bowel disease, chemotherapy-induced gut injury, food allergies, and celiac disease. ...
ByKallyope Inc. based in New York City, NEW YORK (USA)
Many hospitals and EMS agencies across the U.S. have adopted LifeFlow for the initial management of a wide variety of conditions including septic shock, anaphylaxis, post-ROSC hypotension, trauma, and obstetric or gastrointestinal hemorrhage. Accordingly, the intent of the LifeFlow Research program is to assist investigator-initiated resuscitation research. ...
By410 Medical based in Durham, NORTH CAROLINA (USA)
Premium
Modern medical treatments increasingly utilise drug therapy in addition to, or in place of, invasive measures. The growth of new pharmaceutical preparations is today at an unprecedented level. At the same time, increasing regulatory scrutiny over pharmaceutical formulations adds to the challenge for pharmaceutical companies. Jacobi has extensive knowledge of the regulatory and economic challenges faced by pharmaceutical manufacturers, and deep insight into their complex markets. Regardless of the industry sector ...
ByJacobi Group based in Kalmar, SWEDEN
Metagenomics is the study of all microbial genomes present in an environment, from the bottom of the sea to inside our own bodies. If you have shotgun NGS sequencing data, Partek provides powerful, easy-to-use analysis tools to characterize microbial ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...
ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)
Seres’ microbiome therapeutics represent a transformative new approach to ...
BySeres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA)
Heart failure is a chronic condition in which the heart is no longer able to adequately pump blood to meet the demands of the body. It is the progressive weakening of the heart that may impact the function of multiple organs presented as a collection of symptoms. In acute heart failure, the onset of heart failure symptoms and progressive decline can occur rapidly over a short period of ...
ByEvaheart, Inc. (EVI) based in Houston, TEXAS (USA)